• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

CVC invests in FutureLife

  • Wahida Ahmed
  • 22 December 2021
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

CVC Capital Partners has acquired a co-controlling holding in FutureLife, a Prague-based healthcare provider.

CVC is investing via CVC Fund VIII. The vehicle closed on EUR 21.3bn in July 2020, surpassing its target of EUR 17.5bn, according to Unquote Data. The fund targets companies with enterprise values of between EUR 1bn-5bn and equity ticket sizes are usually around EUR 200m-1bn.

The vehicle has invested in Away Resorts, a UK-based recreational services provider, earlier this year in June 2021; and in Business Integration Partners, an Italy-based business support service, in May 2021; it also invested in Ekaterra, a Netherlands-based provider of soft drinks, and Medivet Partnership, a UK-based provider of specialised consumer services. Other investments include Panzani, a France-based food company, and Rayner Surgical Group, a medical supplier based in the UK.

FutureLife

  • DEAL:

    MBO

  • LOCATION:

    Czech Republic

  • SECTOR:

    Healthcare

  • TURNOVER:

    EUR 180m (2021)

  • STAFF:

    1,000

  • VENDOR:

    Hartenburgh Holding

Hartenberg Holding, an investment company, focuses on businesses based in Central Europe; it owns a majority stake in FutureLife.

Mergermarket reported in November 2021 that Hartenberg Holding was pursuing a stake sale and that information memorandums had been distributed for the process, led by Lincoln International and involving a minority stake of at least 30%. It also reported that FutureLife could have an enterprise value of around EUR 480m-600m, based on multiples of 12x-15x its EUR 40m EBITDA. According to a press release, FutureLife is expected to post 2021 revenues of EUR 180m.

Mergermarket reported in May 2020 that the company was pursuing a stake sale - although Hartenburg managing partner Jozef Janov said at the time that the holding was not planning to sell FutureLife or a stake in it even though it was approached by undisclosed strategic investors.

Company
FutureLife is headquartered in Prague and is a provider of IVF, related genetics and women’s health services. It is present across eight European countries including the Czech Republic, the UK, Slovakia, the Netherlands, Romania, Finland, Estonia and Ireland. It performs 39,000 IVF cycles annually and has a workforce of more than 1,000.

People
CVC Capital Partners - István Szőke (managing partner); Cathrin Petty (managing partner and head of healthcare).
FutureLife - Matěj Stejskal (CEO).
Hartenburgh Holding - Jozef Janov (managing partner).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Healthcare
  • CEE
  • CVC Capital Partners
  • Czech Republic

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013